摘要
勃起功能障碍(ED)是影响中老年男性最常见的疾病之一.在过去的几十年中,口服磷酸二酯酶5型抑制剂已被用于治疗ED。多么,怎样这些口服药物需要按需服用,在一些难以治疗的人群中效果不佳.此外,对于ED没有有效的替代治疗方法。基于Prec的结果基因治疗是为长期改善ED及其他相关疾病而设计的一种新的治疗方法,在ED的临床治疗中显示出巨大的潜力。基因治疗利用病毒和非病毒载体通过直接或转导细胞介导的方法将治疗基因传递到组织。随着对分子机制的了解越来越多,我在ED的病理生理过程中,许多治疗基因策略在许多动物模型中得到了广泛的验证和证明。然而,在c中只对其中的几个进行了评估。线状试验。这是由于安全问题,需要解决之前,临床应用可以考虑。本文就ED的基因治疗进展作一综述。治疗,重点是正在出现的基于干细胞的方法以及其他组合策略。基因治疗在ED治疗中的应用也面临着挑战。谈论( discuss的过去式和过去分词 ).
关键词: 勃起功能障碍,基因治疗,细胞治疗,干细胞,基因传递,勃起。
Current Gene Therapy
Title:Advances in Gene Therapy for Erectile Dysfunction: Promises and Challenges
Volume: 18 Issue: 6
关键词: 勃起功能障碍,基因治疗,细胞治疗,干细胞,基因传递,勃起。
摘要: Erectile Dysfunction (ED) is one of the most common conditions affecting middle-aged and older men. Over the past few decades, oral phosphodiesterase type 5 inhibitors have been used to treat ED. However, these oral medications require on-demand access and are not effective in some hard-totreat populations. Moreover, there are no effective alternative treatments for ED. Based on results from preclinical models designed to provide long-term improvement of ED and other related conditions, gene therapy has shown great potential as a novel therapy for clinical management of ED. Gene therapy refers to the use of viral and non-viral vectors to deliver therapeutic genes to tissues via direct or transduced cell-mediated approaches. With the growing knowledge on the molecular mechanisms involved in the pathophysiology of ED, a number of therapeutic gene strategies have been extensively tested and proven to be effective in many animal models. However, only a few of them have been evaluated in clinical trials. This is due to safety concerns that need to be addressed before the clinical application can be considered. In this review, we summarize the key advancements in gene therapy for ED treatment, with an emphasis on the emerging stem cell-based approaches as well as other combinational strategies. The challenges facing the clinical application of gene therapy for ED treatment are also discussed.
Export Options
About this article
Cite this article as:
Advances in Gene Therapy for Erectile Dysfunction: Promises and Challenges, Current Gene Therapy 2018; 18 (6) . https://dx.doi.org/10.2174/1566523218666181004145424
DOI https://dx.doi.org/10.2174/1566523218666181004145424 |
Print ISSN 1566-5232 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5631 |
Call for Papers in Thematic Issues
Programmed Cell Death Genes in Oncology: Pioneering Therapeutic and Diagnostic Frontiers (BMS-CGT-2024-HT-45)
Programmed Cell Death (PCD) is recognized as a pivotal biological mechanism with far-reaching effects in the realm of cancer therapy. This complex process encompasses a variety of cell death modalities, including apoptosis, autophagic cell death, pyroptosis, and ferroptosis, each of which contributes to the intricate landscape of cancer development and ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements